1. Home
  2. LAB vs CANG Comparison

LAB vs CANG Comparison

Compare LAB & CANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAB
  • CANG
  • Stock Information
  • Founded
  • LAB 1999
  • CANG 2010
  • Country
  • LAB United States
  • CANG China
  • Employees
  • LAB N/A
  • CANG N/A
  • Industry
  • LAB Biotechnology: Laboratory Analytical Instruments
  • CANG Computer Software: Prepackaged Software
  • Sector
  • LAB Industrials
  • CANG Technology
  • Exchange
  • LAB Nasdaq
  • CANG Nasdaq
  • Market Cap
  • LAB 435.8M
  • CANG 370.5M
  • IPO Year
  • LAB 2011
  • CANG 2018
  • Fundamental
  • Price
  • LAB $1.24
  • CANG $4.29
  • Analyst Decision
  • LAB Buy
  • CANG
  • Analyst Count
  • LAB 2
  • CANG 0
  • Target Price
  • LAB $2.50
  • CANG N/A
  • AVG Volume (30 Days)
  • LAB 1.2M
  • CANG 222.6K
  • Earning Date
  • LAB 05-06-2025
  • CANG 06-11-2025
  • Dividend Yield
  • LAB N/A
  • CANG N/A
  • EPS Growth
  • LAB N/A
  • CANG N/A
  • EPS
  • LAB N/A
  • CANG 0.35
  • Revenue
  • LAB $174,432,000.00
  • CANG $110,217,499.00
  • Revenue This Year
  • LAB N/A
  • CANG N/A
  • Revenue Next Year
  • LAB $12.77
  • CANG N/A
  • P/E Ratio
  • LAB N/A
  • CANG $11.60
  • Revenue Growth
  • LAB 64.03
  • CANG N/A
  • 52 Week Low
  • LAB $0.97
  • CANG $1.32
  • 52 Week High
  • LAB $2.74
  • CANG $9.66
  • Technical
  • Relative Strength Index (RSI)
  • LAB 56.32
  • CANG 59.14
  • Support Level
  • LAB $0.99
  • CANG $3.49
  • Resistance Level
  • LAB $1.18
  • CANG $3.90
  • Average True Range (ATR)
  • LAB 0.09
  • CANG 0.32
  • MACD
  • LAB 0.02
  • CANG 0.06
  • Stochastic Oscillator
  • LAB 75.00
  • CANG 99.53

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

About CANG Cango Inc. each representing two (2)

Cango Inc through its subsidiaries, variable interest entities (VIEs), and subsidiaries of the VIEs, are principally engaged in bitcoin mining business, and the automobile trading transaction, automotive financing facilitation, and aftermarket service facilitation businesses (collectively, the automobile and related businesses). The Company conducts the bitcoin mining business mainly through its subsidiaries, and the automobile and related businesses are conducted through the Company's VIEs and the subsidiaries of the VIEs. The company derives majority of its revenue from the bitcoin mining business.

Share on Social Networks: